Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 170.50 | 27.78 | 630.45 | 871.08 |
Depreciation/ Depletion | 381.90 | 554.03 | 381.70 | 451.65 |
Non- Cash Items | 373.50 | 228.85 | 197.77 | 605.76 |
Changesin Working Capital | 45.40 | -149.99 | -372.38 | -221.21 |
Cashfrom Operating Activities | 971.30 | 660.67 | 837.54 | 1,707.28 |
Capital Expenditures | -897.70 | -814.45 | -599.99 | -527.49 |
Other Investing Cash Flow Items Total | 289.80 | 270.04 | 219.62 | -211.52 |
Cashfrom Investing Activities | -607.90 | -544.41 | -380.37 | -739.01 |
Financing Cash Flow Items | -243.70 | -234.23 | -134.94 | -292.24 |
Total Cash Dividends Paid | -79.80 | -80.06 | -80.05 | -1.48 |
Issuance( Retirement)of Stock Net | -27.40 | -3.97 | 0.00 | -10.06 |
Issuance( Retirement)of Debt Net | -81.60 | 161.58 | 182.39 | -1,405.62 |
Cashfrom Financing Activities | -432.50 | -156.68 | -32.60 | -1,709.39 |
Foreign Exchange Effects | 11.60 | 70.53 | 57.29 | 12.26 |
Net Changein Cash | -57.50 | 30.10 | 481.86 | -728.86 |
Cash Interest Paid | 243.70 | 234.23 | 134.94 | 292.24 |
Cash Taxes Paid | 207.70 | 204.30 | 194.09 | 394.12 |
Jubilant Pharmova Dividend Jubilant Pharmova Bonus Jubilant Pharmova News Jubilant Pharmova AGM Jubilant Pharmova Rights Jubilant Pharmova Splits Jubilant Pharmova Board Meetings Jubilant Pharmova Key Metrics Jubilant Pharmova Shareholdings Jubilant Pharmova Profit Loss Jubilant Pharmova Balance Sheet Jubilant Pharmova Q1 Results Jubilant Pharmova Q2 Results Jubilant Pharmova Q3 Results Jubilant Pharmova Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks